Medical Outcome Study-HIV Health Survey (MOS-HIV)

The initial MOS-HIV developed in 1991 consisted of 30 items, then the instrument was expanded to 34 items. The final questionnaire consists of 35 items.

WEBINAR: An Author Webinar on the Medical Outcome Study-HIV Health Survey  - Recorded session available here!

Wu AW, Rubin HR, Mathews WC, Ware JE Jr, Brysk LT, Hardy WD, Bozzette SA, Spector SA, Richman DD. A health status questionnaire using 30 items from the Medical Outcomes Study. Preliminary validation in persons with early HIV infection. Med Care. 1991 Aug;29(8):786-98 (PubMed Abstract)

Wu AW, Revicki DA, Jacobson D, Malitz FE. Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV). Qual Life Res. 1997 Aug;6(6):481-93 (PubMed Abstract)

• MOS-HIV User Agreement

* Excluding VAT
Commercial users: Industry, CRO, any for-profit companies
Funded Academic research: Projects receiving funding from commerce, government, EU or registered charity. Funded academic research– sponsored by industry fits the “commercial users” category.
Not funded academic users, individual medical practice: Projects are not explicitly funded, but funding comes from overall departmental funds or from the University or individual funds

The Owner, Dr. Wu Albert, as defined in section 1.02 may be subject to the laws of the United States including without limitation the United States Affordable Care Act of 2010 and specifically the Physician Payments Sunshine Act (the “US Sunshine Act”). Payments made directly to the Owner or through MRT may apply as Royalty Fees under the US Sunshine Act if the User is also subject to the laws as a medical device and drug manufacturers (“Applicable Manufacturers”) or group purchasing organizations (“GPOs”) that commercialize the medical device or drug in the USA.  The User acknowledges that the User may be required to report the Royalty Fees the appropriate party pursuant to the US Sunshine Act. Please consult www.CMS.govfor more information on the Sunshine Act or contact MRT.

Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.

• MOS-HIV in English for the USA

The listed translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study. This list is subject to constant changes, therefore please check the status of translations with Mapi Research Trust / the developers / copyright holders / distributors.

Bibliographic references of the translations:
Ichikawa M, Natpratan C. Quality of life among people living with HIV/AIDS in northern Thailand: MOS-HIV Health Survey. Qual Life Res. 2004 Apr;13(3):601-10
Mast TC, Kigozi G, Wabwire-Mangen F, Black R, Sewankambo N, Serwadda D, Gray R, Wawer M, Wu AW. Measuring quality of life among HIV-infected women using a culturally adapted questionnaire in Rakai district, Uganda. AIDS Care. 2004 Jan;16(1):81-94
Scott-Lennox JA, Wu AW, Boyer JG, Ware JE Jr. Reliability and validity of French, German, Italian, Dutch, and UK English translations of the Medical Outcomes Study HIV Health Survey. Med Care 1999;37:908-25
Zander KJ, Palitzsch M, Kirchberger I, Poppinger J, Jägel-Guedes E, Jäger H, von Steinbuchel N, Bullinger M. HIV-infektion und gesundheitsbezogene Lebensqualität: psychometrische prüfung der deutschsprachigen version de "MOS-HIV"-fragebogens zur therapieerfolgskontrolle. (HIV infection and health related quality of life: psychometric testing of the German version of the MOS-HIV questionnaire. AIDS-Forschung (AIFO) 1994;9:241-249

My study is not funded

• I am a non-commercial user
• I do not receive specific funding for my study
• I intend to use the questionnaire in individual clinical practice or research study